Skip to main content
Clinical Trials/ACTRN12615000345583
ACTRN12615000345583
Completed
Phase 2

A comparison between a new knee guard device and an established non-steroidal anti-inflammatory formulation on function and pain in mild to moderate knee osteoarthritis: A pilot randomised controlled equivalence trial.

OBJ Limited0 sites114 target enrollmentApril 15, 2015

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
knee osteoarthritis
Sponsor
OBJ Limited
Enrollment
114
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 15, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
OBJ Limited

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria:
  • 1\. Males aged 40\-55
  • 2\. Good general health
  • 3\. Currently participating in regular physical activity (\>2 hrs per week)
  • 4\. (a) Prior history of knee injury requiring arthroscopic surgery, and/or, (b) Prolonged history of recurrent knee pain (\>2 / 10 on pain numerical rating scale), and/or (c) A diagnosis of mild to moderate knee osteoarthritis.

Exclusion Criteria

  • Exclusion Criteria:
  • 1\. patellofemoral joint dysfunction
  • 2\. ligamentous deficiency
  • 3\. history of cardiac disease
  • 4\. history of high blood pressure
  • 5\. history of asthma
  • 6\. history of diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials